InflaRx Q1 2024 GAAP EPS $(0.18) Beats $(0.22) Estimate, Sales $39.138K Miss $1.268M Estimate
Portfolio Pulse from Benzinga Newsdesk
InflaRx reported Q1 2024 earnings with a GAAP EPS of $(0.18), surpassing the $(0.22) estimate. However, their sales of $39.138K fell significantly short of the $1.268M estimate, missing by 96.91%.

May 08, 2024 | 11:34 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
InflaRx's Q1 2024 earnings exceeded EPS estimates but missed sales forecasts significantly.
While the better-than-expected EPS might provide some positive sentiment, the significant miss in sales forecasts could raise concerns about revenue growth and operational efficiency, potentially offsetting any positive impact from the EPS beat.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100